Evidence map›Paper›PMID 37620742›Full record

ArticleJournal of clinical immunology2023

Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort.

Hana Grombirikova, Viktor Bily, Premysl Soucek, Michal Kramarek, Roman Hakl, Lucie Ballonova, Barbora Ravcukova, Dita Ricna, Karolina Kozena, Lucie Kratochvilova and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Diagnostic delay,Frontiers in allergy · 2026
    Article
  7. Article
  8. Early diagnosis of hereditary angioedema in children: genetic testing should be prioritized.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Article
  9. Identification of an elusiveFrontiers in allergy · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Pathogenic variant inBMJ case reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Hana GrombirikovaCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Viktor BilyCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Premysl SoucekCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Michal KramarekCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Roman HaklFaculty of Medicine, Masaryk University, Brno, Czech Republic.
Lucie BallonovaCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Barbora RavcukovaCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Dita RicnaCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Karolina KozenaCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Lucie KratochvilovaCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic.
Marta SobotkovaDepartment of Immunology, 2nd Medical School, Charles University and University Hospital Motol, Prague, Czech Republic.
Radana ZachovaDepartment of Immunology, 2nd Medical School, Charles University and University Hospital Motol, Prague, Czech Republic.
Pavel KuklinekFaculty of Science, Masaryk University, Brno, Czech Republic.
Pavlina KralickovaInstitute of Clinical Immunology and Allergy, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
Irena KrcmovaInstitute of Clinical Immunology and Allergy, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.
Jana HanzlikovaDepartment of Immunology and Allergology, University Hospital Pilsen, Pilsen, Czech Republic.
Martina VachovaDepartment of Immunology and Allergology, University Hospital Pilsen, Pilsen, Czech Republic.
Olga KrystufkovaInstitute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Eva DankovaImmunia, Prague, Czech Republic.
Milos JesenakNational Centre for Hereditary Angioedema, Department of Pediatrics, Department of Pulmonology and Pathophysiology, Department of Clinical Immunology and Allergology, Comenius University in Bratislava, Jessenius Faculty of Medicine, University Teaching Hospital in Martin, Martin, Slovakia.
Martina NovackovaInstitute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
Michal SvobodaInstitute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
Jiri LitzmanFaculty of Medicine, Masaryk University, Brno, Czech Republic.
Tomas FreibergerCentre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. tomas.freiberger@cktch.cz.ORCID http://orcid.org/0000-0001-6532-7053
Masaryk University · CZCharles University · CZCentrum kardiovaskulární a transplantační chirurgie · CZComenius University Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare and life-threatening condition characterized by recurrent localized edema. We conducted a systematic screening of SERPING1 defects in a cohort of 207 Czech patients from 85 families with C1-INH-HAE. Our workflow involved a combined strategy of sequencing extended to UTR and deep intronic regions, advanced in silico prediction tools, and mRNA-based functional assays. This approach allowed us to detect a causal variant in all families except one and to identify a total of 56 different variants, including 5 novel variants that are likely to be causal. We further investigated the functional impact of two splicing variants, namely c.550 + 3A > C and c.686-7C > G using minigene assays and RT-PCR mRNA analysis. Notably, our cohort showed a considerably higher proportion of detected splicing variants compared to other central European populations and the LOVD database. Moreover, our findings revealed a significant association between HAE type 1 missense variants and a delayed HAE onset when compared to null variants. We also observed a significant correlation between the presence of the SERPING1 variant c.-21 T > C in the trans position to causal variants and the frequency of attacks per year, disease onset, as well as Clinical severity score. Overall, our study provides new insights into the genetic landscape of C1-INH-HAE in the Czech population, including the identification of novel variants and a better understanding of genotype-phenotype correlations. Our findings also highlight the importance of comprehensive screening strategies and functional analyses in improving the C1-INH-HAE diagnosis and management.

Indexed as

Angioedemas, HereditaryComplement C1 Inhibitor ProteinCzech RepublicHumansRNA, MessengerRNA SplicingComplement C1 Inhibitor ProteinRNA, MessengerSERPING1 protein, humanC1-INH-HAEgenotype–phenotype relationshipHAEhereditary angioedemaSERPING1splicingtime to diagnosis

Identifiers

PMID37620742
PMCPMC10661775
OpenAlexW4386152155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.